Affordable Auto Insurance Quotes for a Bad Driving Record

(PRWEB) October 30, 2014 has released a new blog post explaining how to find affordable auto insurance quotes for clients who have a bad driving record.

When calculating auto insurance prices, agencies pay attention to two important aspects: the vehicle and the applicant’s driving record. Someone who was involved in accidents or has received high fines for his or her reckless driving may have to pay more for vehicle coverage.

However, insurance brokerage websites like can help even drivers with past incidents qualify for affordable coverage.

By comparing online auto insurance quotes, clients can improve their chances of finding affordable coverage. Comparing offers is simple, fast and efficient. is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. is owned by Internet Marketing Company.

For more information, please visit .

NXP SmartMX2 Card Platform Achieves Highest Level of Security for MIFARE Applications

Eindhoven, Netherlands (PRWEB) October 27, 2014

NXP Semiconductors N.V. (NASDAQ:NXPI) today announced that its SmartMX2 technology is the world’s first secure smart card platform with MIFARE Plus and MIFARE DESFire EV1 functionality to be certified at Evaluation Assurance Level (EAL) 5+, the highest level of security offered for MIFARE applications. Achieving EAL5+ certification on MIFARE applications based on SmartMX2 enables services to be taken to the next level – providing, for example, security for electronic health cards or identity cards with a combination of payment and access functionality and/or opening up doors to develop new secure services in banking, e-Government identification, transportation, micro payments, loyalty tracking and more.

“Advanced security is paramount as smart cards quickly transition to all encompassing, multiple-application cards. Being able to offer secure MIFARE applications on SmartMX2 is the next evolutionary step towards this development,” said Ulrich Huewels, senior vice president and general manager, secure identification solutions, NXP Semiconductors. “Securing EAL 5+ certification reaffirms NXP’s commitment to delivering secure connections – ensuring that personal and financial data is protected and safeguarded. Consumers can benefit from the flexibility offered by our MIFARE platforms for payments and access and be confident that their information is secure via our world renowned SmartMX technology.”

Supported by the MIFARE Flex framework, the SmartMX2 family offers developers the convenience of a ready to use solution with the flexibility of a full set of MIFARE Plus and MIFARE DESFire protocol parameters. System designers are also able to optionally use NXP’s common criteria (CC) certified crypto library modules to build their secure applications. Three different certified SmartMX2 platform types support all MIFARE Plus and/or MIFARE DESFire EV1 card data variations and can even be configured with MIFARE Classic to optimize the use of existing infrastructures.

NXP will be showcasing its latest solutions to enable secure connections for a smarter world at CARTES 2014, November 4-6, booth 4M070, Paris-Nord Villepinte Exhibition Centre, Paris, France.

About SmartMX

SmartMX, the platform of choice for secure and fast data transactions, is a proven solution for contact, contactless and dual interface applications covering eGovernment, banking and public transport. It offers advanced attack resistance and high performance, supported by powerful cryptographic coprocessors and ultra-low-power design. SmartMX solutions use NXP’s Integral Security™ architecture which has over 100 security features and combines powerful co-processors for the highest levels of performance.

The SmartMX2 family follows on the proven reliability and interoperability of SmartMX with a further optimized feature set. SmartMX2 provides a new level of RF excellence to support contactless and Dual Interface solutions. Coming with a Common Criteria EAL 6+ certificate for the majority of family members, customers can rely on an unprecedented level of security provided with these secure microcontroller platforms.


MIFARE is NXP´s well-known brand for a wide range of contactless IC products used in more than 40 different applications worldwide. With more than 150 million reader core components and 10 billion contactless and dual interface ICs sold, MIFARE products are one of the most proven and reliable interface technologies in the market. MIFARE products comply with the international standard ISO/IEC 14443 and are backward-compatible within the product families. This ensures that the existing infrastructure can be smoothly upgraded to higher security and feature levels, such as payment systems, ticketing solutions, loyalty programs, access management, and parking. To further extend the reach of MIFARE products, the MIFARE4Mobile Industry Group brings MIFARE applications into NFC-enabled mobile devices.

About NXP Semiconductors

NXP Semiconductors N.V. (NASDAQ: NXPI) creates solutions that enable secure connections for a smarter world. Building on its expertise in High Performance Mixed Signal electronics, NXP is driving innovation in the automotive, identification and mobile industries, and in application areas including wireless infrastructure, lighting, healthcare, industrial, consumer tech and computing. NXP has operations in more than 25 countries, and posted revenue of $ 4.82 billion in 2013. Find out more at


Forward-looking Statements

This document includes forward-looking statements which include statements regarding NXP’s business strategy, financial condition, results of operations and market data, as well as other statements that are not historical facts. By their nature, forward-looking statements are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements. Except for any ongoing obligation to disclose material information as required by the United States federal securities laws, NXP does not have any intention or obligation to publicly update or revise any forward-looking statements after NXP distributes this document, whether to reflect any future events or circumstances or otherwise. For a discussion of potential risks and uncertainties, please refer to the risk factors listed in NXP’s SEC filings. Copies of NXP’s SEC filings are available from the SEC website,

Find More Law Press Releases

Vaginal Mesh Lawsuit News: Boston Scientific Loses Bid for Summary Judgment on Negligence, Warning Claims in Federal Obtryx Case, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) October 23, 2014

The federal judge overseeing thousands of vaginal mesh lawsuits ( filed against Boston Scientific Corp. has denied the company’s Motion for Summary Judgment on negligence and warning claims put forth in one case involving the Obtryx Transobturator Mid-Urethral Sling System. The lawsuit, which is currently pending in the federal multidistrict litigation now underway in the U.S. District Court, Southern District of West Virginia, claims that the Obtryx device caused the plaintiff to suffer erosion, mesh contraction, infection, fistula, inflammation, scar tissue, organ perforation, and other serious vaginal mesh complications. According to an Order issued on October 17th, Judge Joseph R. Goodwin allowed her failure to warn, negligence and breach of warranty claims to go forward after finding that the lawsuit had established issues of fact as to the safety and effectiveness of the device. (Tyree, et al. v. Boston Scientific Corp., No. 2:12-8633)

According to court documents, this lawsuit is one of four Boston Scientific cases involving Obtryx mesh that have been consolidated for the proceeding’s first bellwether trial. That trial is scheduled to begin on November 3, 2014.

“Our Firm is closely monitoring the progress of vaginal mesh lawsuits filed against Boston Scientific Corp. and other companies, as we are representing hundreds of women in claims that put forth similar allegations,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free legal reviews to women who suffered mesh erosion, pain, scarring, infection and other serious transvaginal mesh complications, allegedly due to products marketed by a number of manufacturers.

Transvaginal Mesh Litigation

Court records indicate that Boston Scientific has been named a defendant in more than 14,000 vaginal mesh lawsuits that are currently pending in the Southern District of West Virginia. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving as a member of the Plaintiffs’ Steering Committee for this proceeding. All the claims filed in this litigation similarly allege that pelvic mesh products marketed by Boston Scientific were defectively designed and manufactured, and caused women to suffer a wide variety of painful and debilitating transvaginal mesh complications. (In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation – MDL No. 2326)

Court records indicate that more than 60,000 transvaginal mesh lawsuits are currently pending in several litigations underway in the Southern District of West Virginia. Mr. Grand isalso a member of the Plaintiffs’ Steering Committee for other federal proceedings, including those involving American Medical Systems, Inc. (MDL No. 2325), C.R. Bard, Inc. (MDL 2326) and Ethicon, Inc. (MDL No. 2327).

Mr. Grand was also appointed Co-Liaison Counsel in two multicounty litigations established for C.R. Bard and Ethicon mesh lawsuits in New Jersey’s Atlantic Superior Court. He was also a member of the trial team on the first Ethicon trial, which ended in March 2013 with an $ 11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women who were allegedly harmed by pelvic mesh products used to treat pelvic organ prolapse or stress urinary incontinence may be entitled to pursue a legal claim against the manufacturer of the device. To learn more about filing a vaginal mesh lawsuit, please visit Bernstein Liebhard LLP’s website or the firm’s Facebook page: To arrange for a free legal consultation, please call 800-511-5092

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016


ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP


Find More Legal Press Releases

NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice

Rochelle, Virginia (PRWEB) October 20, 2014

Earle Martin, Chief Executive Officer of NDA Partners LLC, announced today that Ellen Teplitzky, an experienced attorney specializing in business matters and legal support for the pharmaceutical industry, has joined the firm as Director of Legal Services and manager of its legal services practice. NDA Partners provides legal services, including research, expert reports and expert witness and testimony, to top law firms and their clients in cases involving complex issues such as product liability, patent infringement, generic competition, and regulatory agency process. The firm’s expert consultants are some of the most respected and accomplished pharmaceutical scientists and industry executives in the world, including former senior executives from the US Food and Drug Administration (FDA), EU regulatory agencies, and major pharmaceutical companies.

“Ms. Teplitzky brings a level of knowledge and experience to our legal practice that will greatly benefit the law firms we work with and their clients,” said Mr. Martin. “These cases are very complex and demanding, and require a deep understanding of the process and issues. Ms. Teplitzky’s support for our legal engagements will further our goal of providing the high quality services and support that our clients expect.”

Ms. Teplitzky has prior experience as Vice President of Legal Affairs at Aptiv Solutions, a contract research organization (CRO); legal counsel at Clinical Transfer Technology Group, a law firm specializing in legal services for pharmaceutical and biotechnology clients; Director of Contracts & Legal Affairs at PRA International, an international CRO; and Corporate Counsel Consultant with Lexis-Nexis. She was awarded her LLM degree from King’s College (London, England) with Merit, JD degree from Emory University School of Law (Atlanta, GA), and received a BA in History at Emory College.

About NDA Partners

NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 40 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.

More Legal Press Releases

Electric Vehicles Market For Construction, Agriculture And Mining 2015-2025: Latest Industry Analysis, Size, Share, Growth, Trends and Forecast 2025

Albany, NY (PRWEB) October 16, 2014

Electric vehicles for construction, mining and agriculture will be a $ 50 billion market in 2025. Komatsu, John Deere, Caterpillar, and others manufacture the big vehicles – mainly hybrid – while other manufacturers offer smaller, pure-electric versions.

View Full Report at

Pure electric is a legal requirement indoors. Outdoors, fuel saving and better performance attracts. Cranes and man lifters have many applications. Their production volumes are larger than most people realise. So it is with the electric versions set for 253,000 to be sold in 2025. This is an industry about to change radically. For example, in mining, over 90% of the world’s mines are open cast. They are often in remote places up to 4000 meters above sea level, where shipping diesel can cost more than buying it. Consequently, there is now a move to have 350 kW giant haul trucks working the floor and separately the top of the mine with electric rail-veyors lifting the ore from bottom to top. In an all-electric solution new pollution laws can be met, image improved and money saved, the electricity coming from the mine’s own wind turbines and photovoltaics. Battery swapping and fast charging of those batteries means 350 kWh batteries suffice – big but no larger than those in other EV sectors.

Download Detail Report With Complete TOC at

The new report explains all this and gives detailed forecasts, comparisons and assessments. It shows how mines will electrify much more but only after the current bust period of the boom-and-bust that characterises this industry. It shows why the ubiquitous tractor in agriculture will, at last, be electric in volume quantities by 2025 and how new forms of vehicle design are coming. Benchmarking from the 37 categories of electric vehicle that IDTechEx forecasts, the report explains what new technologies will arrive and why. Supercapacitors, new power components, greater modularisation and integration will transform this industry. The report draws on interviews and results of many recent conferences on these sectors.

Related Reports

Electric Vehicle Forecasts, Trends And Opportunities 2015-2025

View Full Report at

This master report summarising and forecasting every sector of the EV industry remains unique. It adds new sectors as they become substantial, the latest being car-like microEVs homologated as quadricycles in Europe. In the last year it has become a more closely integrated market – pure electric and hybrid whether on land, water or airborne. For example, Nissan has launched hybrid cars selling in tens of thousands yearly. The e-bike company Brammo took orders for 4,000 of its $ 20,000 record-breaking e-motorbike on its launch in the USA.

Download Detail Report With Complete TOC at

Previously, e-motorbikes have been merely a curiosity. Many profitable niches are emerging just as the largest major sectors are changing in importance; the industrial and commercial sector is now bigger and much more profitable than e-cars, and is set to remain so for at least eight more years. All components are changing with supercapacitors sometimes replacing or partly replacing batteries and also new types of battery, energy harvesting, power electronics and structure powering growth in this already huge and prosperous business. It is comprehensively forecasted only in this master report and the subsidiary reports on the segments.

Industrial & Commercial Hybrid & Pure Electric Vehicles 2014-2024: Forecasts, Opportunities, Players

View Full Report at

Those selling components for electric vehicles and those wishing to make the vehicles themselves must seek where the majority of the money is spent and will be spent. That must lead them to industrial and commercial electric vehicles because today these represent 60% of the value of the electric vehicle market. Indeed, this sector is set to grow 4.2 times in the next decade. Industrial and commercial electric vehicles include heavy industrial vehicles, the term referring to heavy lifting, as with forklifts.

Download Detail Report With Complete TOC at

Then we have buses, trucks, taxis and the other light industrial and commercial vehicles. There are also a few work boats and commercial boats and one day there will be commercial electric aircraft but this is really a story about the burgeoning demand for off-road industrial vehicles and on-road commercial vehicles. In particular, industrial electric vehicles make industry more efficient and commercial electric vehicles reduce congestion. Both of them greatly reduce pollution and align closely with government objectives concerning industry and the environment, yet they minimally depend on subsidy, in contrast with some other electric vehicle types.

Wireless Power Transmission For Consumer Electronics And Electric Vehicles 2014 – 2024

View Full Report at

Over the next decade, the most vibrant Wireless Power Transmission (WPT) markets will involve the contactless charging of portable and mobile equipment, in particular consumer electronics and electric vehicles and this is the focus of this report. These two aspects go together because the technology is similar, some proposed standards overlap and some suppliers seek to serve both markets.

Download Detail Report With Complete TOC at

Later, this will lead to contactless power for a high proportion of static consumer, industrial and military electronics. For now, it primarily concerns wireless charging of lithium-ion batteries in portable consumer electronics and in land, water and airborne electric vehicles, particularly cars, both hybrid and pure electric. These travel considerable distances and ready availability of standard, convenient ie contactless, charging capability is key to their widespread adoption. To the user of consumer electronics, this is particularly driven by the ever greater functionality and longer hours of use of mobile phones calling for frequent charging, given that the batteries are not improving fast enough.

About Us is the most comprehensive collection of market research reports. services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Blog at

Xarelto Lawsuit News: New Study Says Treatment Strategies For Venous Thromboembolisms Have Bleeding Risks Reports Wright & Schulte LLC

Columbus, OH (PRWEB) October 12, 2014

Wright & Schulte LLC reports a recently released study found that most treatment options for blood clots in veins (venous thromboembolisms) are equally safe and effective yet major bleeding occurred in patients using the anticoagulants including Xarelto. The research, published in the September 17, 2014 issue of the Journal of the American Medical Association, examined eight different anticoagulant drugs, including unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH), combined with vitamin K antagonists, which are also anticoagulants. Researchers from the University of Ottawa, Ontario, Canada, also included 45 randomized trials, which had a total number of 44,989 patients in their analyses. The study found nearly half of a percentage (0.49 percent) of patients had a major bleeding event during three months of treatment with Xarelto (rivaroxaban), and 0.29 percent had a major bleeding episode with Eliquis. The study’s authors concluded that, except for the UFH-vitamin K antagonist combination, all other treatment strategies had bleeding risks similar to the LMWH-vitamin K antagonist combination. As studies continue on the effectiveness of anticoagulants such as Xarelto, court records indicate that Xarelto lawsuits allege that major bleeding events are side-effects of taking the Xarelto blood thinner and there is no antidote to reverse the uncontrolled bleeding, one of which was filed the U.S. District Court, Eastern District of New York (Case No. 1:14-cv-04841-FB-VMS)

[, September 16, 2014.]

The attorneys at Wright & Schulte continue to investigate claims of uncontrolled bleeding due to Xarelto and offer free legal claims to men and women who believe they have experienced bleeding side-effects from Xarelto and other anticoagulant drugs by calling 1-800-399-0795 or by visiting for information on this and other medication news.

Xarelto is a new-generation oral blood thinner first approved by the U.S. Food & Drug Administration (FDA) in July 2011 to reduce deep vein thrombosis and pulmonary embolism in patients who had knee or hip replacement surgery. In November 2011, FDA expanded approval for Xarelto to treat deep being thrombosis. In November 2012, Xarelto was approved to treat and prevent recurrence of deep vein thrombosis and pulmonary embolism and to reduce the risk of the conditions recurring following initial treatment. Unlike warfarin (Coumadin, Jantoven), a blood thinner approved by the FDA in 1954, Xarelto does not have a specific reversal agent should significant bleeding occur. Vitamin K is used as the antidote for patients taking warfarin.

[, November 2, 2012]

[, July 17, 2014]

Court documents indicate that Xarelto lawsuits are being filed in courts throughout the United States, including a wrongful death lawsuit filed on August 14, 2014, in the U.S. District Court, Eastern District of New York on behalf of a 92-year-old Tennessee man. (Case No. 1:14-cv-04841-FB-VMS) According to the Xarelto complaint, the Tennessee man first began using the blood thinner medication from May 2013 and continued to use until August 2013. The Xarelto lawsuit alleges that due to using Xarelto, the man suffered life-threatening bleeding on August 25, 2013, and sustained severe and permanent personal injuries, pain, suffering and emotional distress. The man died on December 6, 2013. The Xarelto complaint purports that defendants Jannssen Pharmaceuticals and Bayer failed to warn emergency room doctors and other medical professionals as well as disclose to patients that there is no effective agent to reverse the anticoagulation effects of Xarelto, and therefore there is no effective means to treat and stabilize patients who experience uncontrolled bleeding while taking Xarelto.

About Wright & Schulte LLC

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free low testosterone lawsuit case evaluations are available through or by calling 1-800-399-0795.


Wright & Schulte LLC

812 East National Road

Vandalia, Ohio 45377


Like us on Facebook

Follow us on Twitter

Join us on Google+

Find More Law Press Releases

Thorvald Nelson Elected to Colorado Humanities Board of Directors

Denver, Co (PRWEB) October 08, 2014

Holland & Hart LLP partner Thorvald Nelson has been elected to the Colorado Humanities board of directors. Providing expertise and relationships throughout the state, board members monitor the Colorado Humanities’ mission, provide fiscal oversight, approve programs, make personal contributions, and participate in conferences and continuing education activities.

“I’m inspired by the organization’s dedication to expanding every Coloradoan’s ability to make

the humanities an every-day part of our lives,” said Thor Nelson, a regulatory lawyer and former

economist. Nelson, who represents a broad spectrum of utility consumers and utilities in regulatory matters at the local, state, and federal level, said he is looking forward to his new board position. “I’m excited to be working with the outstanding team at Colorado Humanities,” he said. “History. Culture. The arts. Those are the things that make life worth living.”

The Colorado Humanities board of directors comprises 20 members. Five board positions are filled by appointment of the governor and 15 through the nonprofit organization’s ongoing nominations process. Colorado Humanities Board Chair William Wei, who is a professor of history at the University of Colorado-Boulder, said, “Once again, Colorado Humanities has attracted stellar board members who are committed to its mission of promoting the humanities in the Centennial State. I look forward to working with them to do so.”

Also joining the board are: Vectra Bank Colorado Market President for Roaring Fork Valley Charles T. Bantis; University of Colorado-Denver Sr. Project Manager in the Office of the Provost/Chancellor Michel R. Dahlin; The Durango Herald Publisher (retired) Richard G. Ballantine; Colorado Northwestern Community College Vice President of Instruction and Student Affairs David M. Smith; and NEX-U President Paulette Grant Tate. Retired Law Partner of Gibson, Dunn & Crutcher LLP George B. Curtis was reappointed by the governor in May for his second term.

During his career, Nelson has appeared before state utility regulatory commissions throughout the Mountain West including Colorado, Wyoming, Utah, Idaho, Montana, and New Mexico. He also represents clients before the Federal Energy Regulatory Commission, in state and federal courts, and before state legislatures.

At Holland & Hart, Nelson has represented large electric consumers and electric consumer coalitions, independent power producers, renewable energy developers, competitive local exchange carriers, cable companies, rural local exchange carriers, natural gas local distribution companies and pipelines, water utilities, and utility consumer organizations.

Nelson’s clients value the industry understanding he gained from serving as an economist with the Colorado Office of Consumer Counsel. While there, he had opportunities to serve as a testifying expert on regulatory law and policy. He was a member of several federal and state bodies responsible for economic and policy recommendations to regulators, including the Staff of the Federal-State Joint Board on Universal Service.

– 30 –

About Colorado Humanities

Colorado Humanities, a 501(c)(3) nonprofit nationally affiliated with the National Endowment for the Humanities, the Center for the Book in the Library of Congress, Letters About Literature, Motheread, Inc., River of Words and the Smithsonian Institution, is the only Colorado organization exclusively dedicated to support humanities education for adults and children statewide. Based in Greenwood Village, Colorado Humanities designs and implements more than a dozen educational programs, and works with 350 local program partners throughout the state to tailor the programs to community needs. The organization’s goals are to improve education, strengthen cultural institutions and enrich community life by providing school-based and community humanities education programs. To learn more, contact the office at (303) 894-7951, or visit You can “friend” Colorado Humanities on Facebook.

About Holland & Hart

Holland & Hart LLP delivers integrated legal solutions to regional, national and international clients of all sizes. Since its inception in 1947, Holland & Hart’s more than 470 lawyers have consistently been recognized by leading national and international peer and industry review organizations for innovation and dedication to the practice of law. For more information, visit

Find More Colorado Press Releases

How To Protect Your Child From Our Accident Epidemic

How To Protect Your Child From Our Accident Epidemic
Accidents Are The Leading Cause Of Death From 1 Through 19. Over 12,000 Children Die Each Year In Accidents, And Millions Are Injured, Many Seriously. This Booklet Has Safety Tips For Over 50 Topics. The Tips Help Parents Develop Personal Safety Plans.
How To Protect Your Child From Our Accident Epidemic

The Car Accident Claims Kit Second Edition
A Top Rated Accident Lawyers Do-it-yourself Guide To Winning Car Insurance Claims.
The Car Accident Claims Kit Second Edition

Cambie Su Vida Con El Secreto… – Change Your Life With The Secret..

Cambie Su Vida Con El Secreto… – Change Your Life With The Secret..
Gane 40% Reciba La Mejor Ayuda De Ventas, Y Cambie Su Vida Con La Ley De Atracción — Earn 40% Receive All The Help That You Need, And Change Your Life With The Law Of Attraction
Cambie Su Vida Con El Secreto… – Change Your Life With The Secret..

Career Cop Law Enforcement Hiring System
Don’t Waste Another Second Working A Job You Don’t Love, It’s Time For You To Start Loving Your Career And Getting Paid Big To Do It! Not To Mention You’ll Be Doing Amazing Things To Better Your Community.
Career Cop Law Enforcement Hiring System